{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:35:22Z","timestamp":1774690522827,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"None"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12098-017-2339-8","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T01:39:42Z","timestamp":1491183582000},"page":"509-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ophthalmic Evaluation in Beta-Thalassemia"],"prefix":"10.1007","volume":"84","author":[{"given":"Rashid H.","family":"Merchant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrishikesh","family":"Punde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neepa","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"2339_CR1","first-page":"28","volume":"6","author":"K Grow","year":"2014","unstructured":"Grow K, Vashist M, Abrol P, Sharma S, Yadav R. Beta thalassemia in India: current status and the challenges ahead. Int J Pharm Pharm Sci. 2014;6:28\u201333.","journal-title":"Int J Pharm Pharm Sci"},{"key":"2339_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135\u201346.","journal-title":"N Engl J Med"},{"key":"2339_CR3","first-page":"95","volume":"60","author":"BG Forget","year":"1993","unstructured":"Forget BG. The pathophysiology and molecular genetics of beta thalassemia. Mt Sinai J Med. 1993;60:95\u2013103.","journal-title":"Mt Sinai J Med"},{"key":"2339_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/beha.2002.0214","volume":"15","author":"JB Porter","year":"2002","unstructured":"Porter JB, Davis BA. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Pract Res Clin Haematol. 2002;15:329\u201348.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2339_CR5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1167\/iovs.08-2850","volume":"50","author":"H Chen","year":"2009","unstructured":"Chen H, Lukas T, Du N, Suyeoka G, Neufeld A. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. Invest Ophthalmol Vis Sci. 2009;50:1895\u2013902.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2339_CR6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1167\/iovs.10-6207","volume":"52","author":"M Hadziahmetovic","year":"2011","unstructured":"Hadziahmetovic M, Song Y, Wolkow N, et al. The oral iron chelator deferiprone protects against iron overload\u2013induced retinal degeneration. Invest Ophthalmol Vis Sci. 2011;52:959\u201368.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2339_CR7","first-page":"1","volume":"2015","author":"M Di Nicola","year":"2015","unstructured":"Di Nicola M, Giulio B, Dell\u2019Arti L, Ratiglia R, Viola F. Functional and structural abnormalities in deferoxamine retinopathy: a review of the literature. Bio Med Res Int. 2015;2015:1\u201312.","journal-title":"Bio Med Res Int"},{"key":"2339_CR8","doi-asserted-by":"crossref","unstructured":"Masera N, Rescaldani C, Azzolini M, et al. Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox (ICL670) at the pediatric Clinic in Monza, Italy. Haematologica. 2008;93:e9\u201310.","DOI":"10.3324\/haematol.11782"},{"key":"2339_CR9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/IAE.0b013e318074c290","volume":"27","author":"RW Wong","year":"2007","unstructured":"Wong RW, Richa DC, Hahn P, Green WR, Dunaief JL. Iron toxicity as a potential factor, in AMD. Retina. 2007;27:997\u20131003.","journal-title":"Retina"},{"key":"2339_CR10","first-page":"633","volume":"8","author":"DSM Malak","year":"2012","unstructured":"Malak DSM, Dabbous OAE, Saif MYS, Saif ATS. Ocular manifestations in children with B thalassemia major and visual toxicity of iron chelating agents. J Am Sci. 2012;8:633\u20138.","journal-title":"J Am Sci"},{"key":"2339_CR11","first-page":"699","volume":"108","author":"A Gaba","year":"1998","unstructured":"Gaba A, Souza PD, Chandra J, Narayan S, Sen S. Ocular abnormalities in patients with beta thalassemia. Am J Opthalmol. 1998;108:699\u2013703.","journal-title":"Am J Opthalmol"},{"key":"2339_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0301-4738.60083","volume":"58","author":"R Taneja","year":"2010","unstructured":"Taneja R, Malik P, Sharma M, Agarwal MC. Multiple transfused thalassemia major: ocular manifestations in a hospital-based population. Indian J Ophthalmol. 2010;58:125\u201330.","journal-title":"Indian J Ophthalmol"},{"key":"2339_CR13","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2006.04.030","volume":"142","author":"A Taher","year":"2006","unstructured":"Taher A, Bashshur Z, Shamseddeen WA, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142:704\u20135.","journal-title":"Am J Ophthalmol"},{"key":"2339_CR14","first-page":"17","volume":"3","author":"J Rohul","year":"2013","unstructured":"Rohul J, Maqbool A, Hussain SA, Shamila H, Anjum F, Hamdani ZA. Prevalence of refractive errors in adolescents in out- patient attendees of the preventive ophthalmology clinic of community medicine, S K I M S, Kashmir. India Nitte Uni J Health Sci. 2013;3:17\u201320.","journal-title":"India Nitte Uni J Health Sci"},{"key":"2339_CR15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1034\/j.1600-0420.2000.078005512.x","volume":"78","author":"SP Gartaganis","year":"2000","unstructured":"Gartaganis SP, Zoumbos N, Koliopoulos JX, Mela EK. Contrast sensitivity function in patients with beta-thalassemia major. Acta Ophthalmol Scand. 2000;78:512\u20135.","journal-title":"Acta Ophthalmol Scand"},{"key":"2339_CR16","first-page":"11","volume":"5","author":"P Dewan","year":"2011","unstructured":"Dewan P, Gomber S, Chawla H, Rohatgi J. Ocular changes in multi-transfused children with \u03b2-thalassaemia receiving desferrioxamine: a case-control study. South Afr J Child Health. 2011;5:11\u20134.","journal-title":"South Afr J Child Health"},{"key":"2339_CR17","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/OPTH.S35627","volume":"6","author":"M Eleftheriadou","year":"2012","unstructured":"Eleftheriadou M, Theodossiadis P, Rouvas A, Alonistiotis D, Theodossiadis G. New optical coherence tomography fundus findings in a case of beta-thalassemia. Clin Ophthalmol. 2012;6:2119\u201322.","journal-title":"Clin Ophthalmol"},{"key":"2339_CR18","unstructured":"Jalali S, Holder GE, Ram LSM, Vedantam V. Visual Electrophysiology in the Clinic: A Basic Guide to Recording and Interpretation. CME Series, no. 17. New Delhi: All India Ophthalmological Society; 2015. p. 1\u20138."},{"key":"2339_CR19","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/01.CIR.0000031161.77536.02","volume":"106","author":"N Ishizaka","year":"2002","unstructured":"Ishizaka N, Saito K, Mitani H, et al. Iron overload augments angiotensin II-induced cardiac fibrosis and promotes neointima formation. Circulation. 2002;106:1840\u20136.","journal-title":"Circulation"},{"key":"2339_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2003-09-3167","volume":"104","author":"MJ Cunningham","year":"2004","unstructured":"Cunningham MJ, Macklin EA, Neufeld EJ. Cohen AR; thalassemia clinical research network. Complications of beta-thalassemia major in North America. Blood. 2004;104:34\u20139.","journal-title":"Blood"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-017-2339-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-017-2339-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T04:19:05Z","timestamp":1498191545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-017-2339-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2339"],"URL":"https:\/\/doi.org\/10.1007\/s12098-017-2339-8","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}